Zydus Hospital has introduced Next-Generation Sequencing (NGS), a molecular tool for detecting genetic mutations linked to ...
The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML ...
More than 5 years after the American Society of Clinical Oncology warned of emerging disparities in precision medicine, ...
The American College of Medical Genetics and Genomics (ACMG) has made considerable efforts to establish such guidelines and benchmarks for clinical NGS testing, but it is difficult to compare ...
Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter ...
7d
The Punch on MSNRe: Why capillary electrophoresis is reliable for paternity tests – ExpertYour recent article “Why capillary electrophoresis is reliable for paternity Tests—Expert” (March 4, 2025) presents an important discussion on DNA analysis methods. However, it does not fully reflect ...
Efficacy and safety of disitamab vedotin combined with toripalimab as neoadjuvant treatment for patients with locally advanced muscle-invasive bladder cancer: A mono-institutional retrospective study.
As Nigeria continues to grapple with a surge in paternity disputes, scientists say Sanger sequencing via Capillary ...
Discover how automated liquid handling integration is revolutionizing NGS library preparation in genomic workflows.
Hosted on MSN1mon
RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatmentDifferent genomic alterations in DNA damage repair (DDR) pathways occur in 20% to 25% of advanced prostate cancer, including homologous recombination repair (HRR) gene alterations. Identifying the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results